Security key
09075F404
Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO)
CUSIP: 09075F404
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 244,406
- Total 13F value
- $417,230
- Share change
- +143,972
- SEC-reported price per share
- $1.71
- Number of holders
- 29
- Value change
- +$180,899
- Number of buys
- 13
- Number of sells
- 11
- Shares outstanding
- 11,229,947
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
29
Top holders
10
BNGO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Bionano Genomics, Inc. SEC filings
Bionano Genomics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075F404
Recent filing periods:
Ownership snapshot
Top reported holders of BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Lincoln Alternative Strat...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Ayrton Capital LLC
Showing 1-6 of 15 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 5
Ayrton Capital LLC
10%
CVI Investments, Inc.
7.7%
Lincoln Alternative Strategies LLC
5.4%
INTRACOASTAL CAPITAL, LLC
5%
Iroquois Capital Management, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
10%
|
$903,140
528,245 shares
|
$0 | 30 Sep 2025 |
| CVI Investments, Inc. |
13D/G
|
7.7%
|
$1,284,000
10,700,000 shares
|
$0 | 03 Jan 2025 |
| Lincoln Alternative Strategies LLC |
13D/G
|
5.4%
|
$2,021,250
525,000 shares
|
$0 | 17 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$1,957,398
508,415 shares
|
$0 | 16 Sep 2025 |
| Iroquois Capital Management, LLC |
13D/G
Richard Abbe
|
5%
|
$1,088,384
98,944 shares
|
$0 | 30 Sep 2025 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.36%
|
$131,000
40,076 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
244,406
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
25
Q3 2025 holders
29
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend